A Comparison of Two Total Hip Replacements: Hip Resurfacing System Versus Mallory-Head/Exeter
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00116948|
Recruitment Status : Completed
First Posted : July 1, 2005
Last Update Posted : December 5, 2014
|Condition or disease||Intervention/treatment||Phase|
|Osteoarthrosis||Device: ReCap, Hip resurfacing system, Biomet||Phase 4|
In Denmark approximately 7000 primary hip replacements are implanted yearly, and the incidence is rising with the increasingly aging population. For older patients, the incidence of later revisions of hip implantation is low. Unfortunately, this is not true for younger patients. Approximately 20% of patients under 55 years of age at the time of surgery must have the hip implant renewed within 10 years.
This is primarily because of the wear generated by polyethylene debris. The polyethylene is associated with osteolysis in the proximity of the prosthesis leading to failure of the prosthesis.
This unsatisfactory result has led to the development of an alternative hip prosthesis especially to benefit younger and physically active people. The new prosthesis should produce less inflammatory debris and less osteolysis induced failure.
To avoid the polyethylene particles, a new type of prosthesis has been made articulating metal on metal. The Hip Resurfacing System consists of an alloy of chrome - cobalt - molybdenum. Another point of interest for this prosthesis is also the size of the articulating surfaces which are bigger than usual. This will theoretically participate in the generation of metal ions.
- This randomised prospective study will investigate the emission of Co-, Cr- and Mb-ions from Hip Resurfacing System and Mallory-Head/Exeter implants, respectively. The emission is measured as the ion concentration in the urine and is correlated to the inflammatory response in fasting plasma before and after the operation.
- To assess the walking pattern postoperatively using a 3D gait analysis, Vicon Polygon.
- To assess the postoperative recovery using the Harris hip score and visual analogue scale.
- The migration of acetabular components will be evaluated by RSA, performing radiostereometric analyses at the Orthopaedic Center, Aarhus University Hospital. The follow-up RSA will be scheduled for week 1, as well as 3 months, 12 months, 24 months, and 5 years after surgery. Bone mineral density around the implanted femoral component will be examined by DEXA scan at week 1, as well as 1 year and 2 years after surgery.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||50 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||A Comparison of Two Total Hip Replacements: Hip Resurfacing System Versus Mallory-Head/Exeter|
|Study Start Date :||January 2005|
|Actual Primary Completion Date :||September 2011|
|Actual Study Completion Date :||January 2012|
- Device: ReCap, Hip resurfacing system, Biomet
ReCap total hip arthroplasty inserted according to manufactures manual.
- Metal ion release evaluated in urine [ Time Frame: three years ]
- Gait pattern evaluated with 3D gait analysis, Vicon Polygon [ Time Frame: two years ]
- Bone mineral density (BMD) in surrounding bone of the prosthesis [ Time Frame: three years ]
- Prostheses migration evaluated by radiostereometric analysis (RSA) [ Time Frame: three years ]
- Proinflammatory- and bone degradation measures in blood samples [ Time Frame: three years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00116948
|Orthopaedic Center, Aarhus University Hospital|
|Aarhus, Jylland, Denmark, 8000|
|Principal Investigator:||Kjeld Søballe, MD., Prof.||Orthopaedic Center, Aarhus University Hospital, Aarhus, Denmark|